CDC42P1

Across TCGA pan-cancer cohorts, CDC42P1 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of CDC42P1’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where CDC42P1 RNA is repressed in tumor relative to normal tissue. In most cancer types CDC42P1 is over-expressed in tumor, although a few such as UCEC show the opposite, repressed pattern.

UCEC, BRCA, and HNSC are the cancer types where CDC42P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CDC42P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	IV	−0.320	.003	6	view →
BRCA	All	All	+0.134	.047	2	view →
HNSC	All	All	+0.051	.042	2	view →
LUAD	All	All	+0.272	.035	1	view →
THCA	Female	III,IV	+0.083	.042	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

CDC42P1–UCEC

Open the UCEC breakdown →